NCT00070070View on ClinicalTrials.gov

Vaccine Therapy in Treating Patients With Transitional Cell Carcinomas

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

October 28, 2003

Primary Completion Date

January 3, 2006

Study Completion Date

September 30, 2013

Conditions
Transitional Cell Carcinoma
Interventions
BIOLOGICAL

TICE®-strain BCG

BIOLOGICAL

NY-ESO-1 protein

BIOLOGICAL

sargramostim

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

Sponsors
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Ludwig Institute for Cancer Research

OTHER